| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Studies |
Department of Nephrology-Internal Medicine (A.G., P.B., A.F.), Laboratory of Immunology (V.F., C.D., P.L.), Radiology Department (A.W.), Faculty of Pharmacy (M.B.), Centre Hospitalier Universitaire Amiens-Hôpital Sud, 80054 Amiens Cedex 1, France
Address all correspondence and requests for reprints to: Professor A. Fournier, Department of Nephrology-Internal Medicine, Centre Hospitalier Universitaire Amiens-Hôpital Sud, Avenue Laennec-Salouel, 80054 Amiens Cedex 1, France.
Calcium stone formers (CaSF) with idiopathic hypercalciuria (IH) have
been shown to have decreased bone mineral density (BMD). The mechanism
of their bone loss remains obscure. Monokines like interleukin-1ß
(IL-1ß), IL-6, tumor necrosis factor-
(TNF-
), and granulocyte
macrophage stimulating factor (GM-CSF) are involved in bone remodeling,
but only IL-1 excess has been incriminated in the bone loss of CaSF
with IH. Therefore, to more precisely delineate the role of monocyte
activation in the pathogenesis of bone loss in these patients, we
studied the production of IL-1ß, IL-6, TNF-
, and GM-CSF by
unstimulated or lipopolysaccharide (LPS)-stimulated cultured peripheral
blood monocytes in 15 CaSF with IH, in 10 CaSF with dietary
calcium-dependent hypercalciuria (DH), and in 10 healthy controls (C).
Cytokines were measured in the culture medium by sensitive
enzyme-linked immunosorbent assay and vertebral BMD by single energy
computed tomography. The decrease of vertebral BMD in IH compared with
DH, was confirmed (Z score: -1.2 ± 0.2 vs.
-0.5 ± 0.2; P = 0.04; Mann-Whitney). In the
supernatant of unstimulated peripheral blood monocytes, IL-1ß and
TNF-
levels were higher in IH than in C (respectively, 40 ± 21
vs. 7 ± 1 pg/mL, P = 0.008 and
236 ± 136 vs. 39 ± 23 pg/mL,
P = 0.03); those of GM-CSF were greater in IH than
in DH and C (respectively, 52 ± 27 vs. 6 ±
2, P = 0.04 and 6 ± 2 pg/mL,
P = 0.01) and those of IL-6 were not significantly
different among the groups. After in vitro stimulation
by LPS (10 µg/mL), the levels of the various monokines were not
significantly different. In IH patients, the post-LPS levels of IL-6
were negatively correlated to vertebral BMD (n = 15, Z =
-1.97, P = 0.04; Spearman), whereas those of
GM-CSF were positively related to vertebral BMD (n = 15, Z =
2.01, P = 0.04).
In this study, calcium stone formers with IH have bone mineral decrease
and a particular profile of peripheral blood monocytes activation. This
latter is characterized by a spontaneously increased synthesis of
IL-1ß, TNF-
, and GM-CSF. Furthermore, post-LPS levels of IL-6 and
GM-CSF are correlated with vertebral BMD. These results suggest that
monocyte activation may be involved in the bone loss of calcium stone
formers with IH.
This article has been cited by other articles:
![]() |
A. Pasch, F. J. Frey, U. Eisenberger, M. G. Mohaupt, and O. Bonny PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers Nephrol. Dial. Transplant., April 8, 2008; (2008) gfn091v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Favus, A. J. Karnauskas, J. H. Parks, and F. L. Coe Peripheral Blood Monocyte Vitamin D Receptor Levels Are Elevated in Patients with Idiopathic Hypercalciuria J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4937 - 4943. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. ARIS, A. R. STEPHENS, D. A. ONTJES, A. DENENE BLACKWOOD, R. K. LARK, M. B. HENSLER, I. P. NEURINGER, and G. E. LESTER Adverse Alterations in Bone Metabolism Are Associated with Lung Infection in Adults with Cystic Fibrosis Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1674 - 1678. [Abstract] [Full Text] |
||||
![]() |
J. S. Adams, C. F. Song, and V. Kantorovich Rapid Recovery of Bone Mass in Hypercalciuric, Osteoporotic Men Treated with Hydrochlorothiazide Ann Intern Med, April 20, 1999; 130(8): 658 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Thomas Low BMD in Calcium Stone Formers with Hypercalciuriak J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1401a - 1402. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |